A 6-hour-old term newborn (born through thick meconium-stained amniotic fluid) presents with severe respiratory distress (RR 95/min, severe intercostal and subcostal retractions, nasal flare), SpO₂ 78% on 60% FiO₂, and a blood gas showing pH 7.18, PaCO₂ 58 mmHg, PaO₂ 52 mmHg. Chest X-ray shows extensive bilateral infiltrates with hyperinflation. The infant is irritable and has poor perfusion. What is the most appropriate immediate next step in management?

Explanation

## Severe MAS with PPHN: Recognition and Management ### Clinical Severity Assessment **Key Point:** This infant has **severe MAS with signs of persistent pulmonary hypertension of the newborn (PPHN)**: - Severe hypoxemia (SpO₂ 78% on 60% FiO₂) - Severe respiratory acidosis (pH 7.18, PaCO₂ 58) - Severe hypoxemia on ABG (PaO₂ 52) - Extensive bilateral infiltrates on CXR - Poor perfusion and irritability (signs of right-to-left shunting) ### PPHN Indicators in MAS | Sign | Significance | |------|---------------| | Hypoxemia disproportionate to CXR findings | Right-to-left shunting across fetal channels | | Labile SpO₂ with handling | Pulmonary vasoconstriction triggered by stimulation | | Poor perfusion + respiratory distress | Systemic hypotension from RV failure | | Hypercarbia despite ventilation | Severe pulmonary vascular resistance | ### Management Escalation for Severe MAS + PPHN ```mermaid flowchart TD A[Severe MAS: SpO₂ < 85% on high FiO₂]:::outcome --> B[Start conventional mechanical ventilation]:::action B --> C{Response to conventional ventilation?}:::decision C -->|Good: SpO₂ > 90%, pH normalizing| D[Continue CMV, wean FiO₂]:::action C -->|Poor: SpO₂ < 85% despite CMV| E[Escalate to HFO + iNO]:::action E --> F{Signs of PPHN?}:::decision F -->|Yes: labile SpO₂, poor perfusion| G[Initiate inhaled nitric oxide]:::action F -->|No| H[Continue HFO alone]:::action G --> I{Refractory PPHN?}:::decision I -->|Yes: SpO₂ < 80% despite HFO + iNO| J[Consider ECMO]:::urgent I -->|No| K[Wean HFO + iNO as tolerated]:::action ``` **High-Yield:** The combination of **HFO + inhaled nitric oxide (iNO)** is the standard escalation for severe MAS with PPHN refractory to conventional ventilation. ### Why HFO + iNO? 1. **HFO:** Reduces barotrauma and volutrauma; maintains oxygenation at lower mean airway pressures; reduces CO₂ retention. 2. **iNO:** Selective pulmonary vasodilator; reduces pulmonary vascular resistance; improves right-to-left shunting without systemic hypotension. **Clinical Pearl:** Surfactant is NOT routinely indicated in uncomplicated MAS (the lungs produce adequate surfactant). However, if there is concurrent respiratory distress syndrome or severe lung injury, surfactant may be considered. **Warning:** Do NOT delay escalation to HFO + iNO in refractory cases. Prolonged hypoxemia and acidosis increase the risk of PPHN progression and multi-organ failure.